Valuation: Pfizer Limited

Market Cap 165B 1.74B 1.55B 1.44B 1.3B 2.43B 2.48B 17.28B 6.84B 86.58B 6.53B 6.39B 273B P/E 2027 *
20x
P/E 2028 * 17.7x
Enterprise Value 165B 1.74B 1.55B 1.44B 1.3B 2.43B 2.48B 17.28B 6.84B 86.58B 6.53B 6.39B 273B EV / Sales 2027 *
6.24x
EV / Sales 2028 * 5.72x
Free-Float
33.05%
Yield 2027 *
1.73%
Yield 2028 * 1.89%
1 day-2.08%
1 week-5.29%
Current month-6.79%
1 month-10.26%
3 months-22.36%
6 months-24.48%
Current year-27.58%
1 week 3,589
Extreme 3589
3,840.6
1 month 3,589
Extreme 3589
4,123.9
Current year 3,589
Extreme 3589
5,257
1 year 3,589
Extreme 3589
5,346
3 years 3,589
Extreme 3589
6,451.15
5 years 3,408
Extreme 3408
6,451.15
10 years 1,642
Extreme 1642
6,451.15
Manager TitleAgeSince
Chief Executive Officer 55 2023-04-02
Chief Tech/Sci/R&D Officer - 2023-03-31
Chief Operating Officer 48 2023-10-27
Director TitleAgeSince
Chairman 73 1999-12-06
Director/Board Member 63 2019-03-07
Director/Board Member 55 2023-04-02
Change 5-day change 1-year change 3-year change Capi.($)
-2.08%-5.29%-31.81%-8.05% 1.74B
-2.54%+1.31%+55.10%+120.84% 1,135B
-1.42%+3.23%+37.07%+74.26% 636B
+0.16%+0.08%+25.14%+97.36% 505B
-0.31%+3.09%+43.92%+64.55% 378B
-1.34%-0.47%+66.63%+40.56% 358B
-0.68%+2.65%+22.46%+51.48% 295B
-1.20%+3.04%+2.62%+26.97% 266B
-1.79%+1.57%+49.97%+60.87% 237B
-0.73%-0.10%+29.24%+101.19% 193B
Average -0.81%+1.42%+30.04%+63.00% 400.61B
Weighted average by Cap. -0.26%+2.66%+40.96%+82.09%

Financials

2027 *2028 *
Net sales 26.5B 279M 249M 230M 209M 390M 397M 2.77B 1.1B 13.88B 1.05B 1.03B 43.77B 28.92B 305M 272M 251M 228M 426M 433M 3.02B 1.2B 15.15B 1.14B 1.12B 47.76B
Net income 8.28B 87.21M 77.88M 71.94M 65.2M 122M 124M 866M 343M 4.34B 327M 320M 13.67B 9.36B 98.64M 88.08M 81.37M 73.74M 138M 140M 979M 388M 4.91B 370M 362M 15.47B
Net Debt - -
Projected Income Statement - Annual - Pfizer Limited
Logo Pfizer Limited
Pfizer Limited (Pfizer) is an India-based multinational pharmaceutical company focusing on therapy in four business categories, namely, Vaccines, Hospitals, Internal Medicine, and Inflammation and Immunology. Pfizer’s Vaccines Division focuses on Prevenar 13, a Pneumococcal Conjugate Vaccine approved for administering to individuals of all ages against pneumococcal disease, an infection caused by streptococcus pneumoniae bacteria. Internal Medicine portfolio includes approximately 17 specialties and seven therapy areas, including respiratory, multivitamin and multimineral, gastrointestinal, pain, neuroscience, cardiovascular and women’s healthcare. Pfizer Hospital Business Unit focuses on providing advanced anti-infectives to institutions such as hospitals and nursing homes. Inflammation and Immunology focuses on discovering and developing novel therapeutics for chronic autoimmune diseases. Its brands include Prevenar13, CorexDX, Dolonex, Enbrel, Becosules and Folvite, among others.
Employees
1,244
Date Price Change Volume
26-10-23 ₹3,612.30 -2.08% 19,151
26-10-22 ₹3,688.90 -1.75% 29,568
26-10-21 ₹3,754.70 -1.42% 12,027
26-10-19 ₹3,808.70 -0.14% 15,484
26-10-16 ₹3,814.00 +0.08% 39,469

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Pfizer Limited
  1. Stock Market
  2. Stocks
  3. PFIZER Stock